Login

Ex-Hyflux CEO Olivia Lum and ex-CFO, along with four others, charged in court amid corporate governance issues. 00:10:00

Share On Facebook Share On Twitter

Olivia Lum is Chairman/CEO at Hyflux Ltd.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Marc Lasry Discusses Economic Opportunities and Investments | Marc Lasry, CEO , Avenue Capital Group.
00:10:00
Every client has a unique investment goal|Leow Kai Chuen,Vice President,Paragon Capital Management
00:10:00
Enhancing Business Travel with Premium Service and Innovative Technology
00:10:00
CEO Chip Paucek on Navigating the Political Climate | Chip Paucek, CEO , 2U Inc.
00:10:00
Mats Karlsson Landré and I discuss data diodes and OT. | Marie Bengtsson, CEO, Advenica AB (publ) ADVE:STO
00:10:00
Announcing Sunrun CEO Mary Powell as keynote speaker, highlighting her dynamic career from leading Green Mountain Power to reshaping the energy sector.
00:10:00
Mutares CEO Robin Laik on Transforming Companies for Profit | Robin Laik , CEO, Mutares.
00:10:00
The Next Big Thing: Showcasing Startups that are Changing the World|Arash Ferdowsi,Angel Investor,Arash Ferdowsi
00:10:00
Continental Gold Prepares for Production at Buritica Gold Project in Colombia
00:10:00
AMEX Exploration's High-Grade Gold Project Update and Upcoming Catalysts
00:10:00
VC Firm investing in the lifesciences|Daniel Yadegar,Chief Medical Officer,Newpath Partners
00:10:00
CapMan's Emphasis on Dividends: Insights from CEO Joakim Frimodig | Joakim Frimodig, CEO, CapMan.

© 2026 Nehu